Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1996 2
2002 1
2003 3
2004 1
2008 1
2010 1
2012 1
2013 2
2015 2
2016 1
2017 3
2018 2
2019 3
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine.
Curto-Barredo L, Giménez-Arnau AM. Curto-Barredo L, et al. G Ital Dermatol Venereol. 2019 Aug;154(4):444-456. doi: 10.23736/S0392-0488.19.06274-6. Epub 2019 Feb 4. G Ital Dermatol Venereol. 2019. PMID: 30717573 Review.
The second-generation H1-antihistamines (sgAH) are the first-line symptomatic treatment of patients with chronic spontaneous urticaria (CSU). Up to 50% of the patients will not respond to licensed doses of sgAH. ...This revision examines the available literature for …
The second-generation H1-antihistamines (sgAH) are the first-line symptomatic treatment of patients with chronic spontaneous urtic
Treatment of Refractory Chronic Urticaria.
Mehta A, Godse K, Patil S, Nadkarni N, Gautam M. Mehta A, et al. Indian J Dermatol. 2015 May-Jun;60(3):230-7. doi: 10.4103/0019-5154.156325. Indian J Dermatol. 2015. PMID: 26120147 Free PMC article. Review.
Chronic spontaneous urticaria is a distressing disease encountered frequently in clinical practice. ...This article examines the available literature for frequently used agents including systemic corticosteroids, leukotriene receptor antagonists, dapsone, sulfasalaz
Chronic spontaneous urticaria is a distressing disease encountered frequently in clinical practice. ...This article examines t
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials.
Eljaaly K, Alireza KH, Alshehri S, Al-Tawfiq JA. Eljaaly K, et al. Travel Med Infect Dis. 2020 Jul-Aug;36:101812. doi: 10.1016/j.tmaid.2020.101812. Epub 2020 Jul 6. Travel Med Infect Dis. 2020. PMID: 32645478 Free PMC article.
BACKGROUND: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effects versus placebo. ...
BACKGROUND: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effec …
Treatment of urticarial vasculitis: A systematic review.
Kolkhir P, Grakhova M, Bonnekoh H, Krause K, Maurer M. Kolkhir P, et al. J Allergy Clin Immunol. 2019 Feb;143(2):458-466. doi: 10.1016/j.jaci.2018.09.007. Epub 2018 Sep 27. J Allergy Clin Immunol. 2019. PMID: 30268388
In total, 261 eligible studies and 789 unique patients with UV were included in the systematic review. Most patients with UV are adult women with chronic (6 weeks) and systemic disease. UV is mostly idiopathic but can be associated with drugs, malignancy, autoimmunity, and …
In total, 261 eligible studies and 789 unique patients with UV were included in the systematic review. Most patients with UV are adult women …
Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.
Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Reeves GE, et al. Intern Med J. 2004 Apr;34(4):182-6. doi: 10.1111/j.1444-0903.2004.00532.x. Intern Med J. 2004. PMID: 15086698 Clinical Trial.
BACKGROUND: Chronic urticaria (CU) imposes profound impairment on quality of life. ...OBJECTIVE: The aim of the chronic autoimmune urticaria study and evaluation was to evaluate the efficacy of hydroxychloroquine in patients with chronic
BACKGROUND: Chronic urticaria (CU) imposes profound impairment on quality of life. ...OBJECTIVE: The aim of the chronic
Chronic urticaria: a role for newer immunomodulatory drugs?
Tedeschi A, Airaghi L, Lorini M, Asero R. Tedeschi A, et al. Am J Clin Dermatol. 2003;4(5):297-305. doi: 10.2165/00128071-200304050-00001. Am J Clin Dermatol. 2003. PMID: 12688835 Review.
Chronic urticaria is now recognized as an autoreactive disorder in a substantial fraction of patients. ...Other immunomodulating drugs that have been tried in chronic urticaria patients include hydroxychloroquine, dapsone, sulfasalazine and meth
Chronic urticaria is now recognized as an autoreactive disorder in a substantial fraction of patients. ...Other immunomodulati
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.
Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, Godmer P, Abasq C, Astudillo L, Belenotti P, Bessis D, Bigot A, Doutre MS, Ebbo M, Guichard I, Hachulla E, Héron E, Jeudy G, Jourde-Chiche N, Jullien D, Lavigne C, Machet L, Macher MA, Martel C, Melboucy-Belkhir S, Morice C, Petit A, Simorre B, Zenone T, Bouillet L, Bagot M, Frémeaux-Bacchi V, Guillevin L, Mouthon L, Dupin N, Aractingi S, Terrier B; French Vasculitis Study Group. Jachiet M, et al. Arthritis Rheumatol. 2015 Feb;67(2):527-34. doi: 10.1002/art.38956. Arthritis Rheumatol. 2015. PMID: 25385679 Free article.
METHODS: We conducted a French nationwide retrospective study that included 57 patients with chronic urticaria, histologic leukocytoclastic vasculitis, and hypocomplementemia. ...Patients with HUV typically presented with low C1q levels and normal C1 inhibitor level …
METHODS: We conducted a French nationwide retrospective study that included 57 patients with chronic urticaria, histologic leu …
Treatment of refractory chronic urticaria: current and future therapeutic options.
Asero R, Tedeschi A, Cugno M. Asero R, et al. Am J Clin Dermatol. 2013 Dec;14(6):481-8. doi: 10.1007/s40257-013-0047-3. Am J Clin Dermatol. 2013. PMID: 24085572 Review.
Chronic urticaria is a distressing disease that affects up to 1 % of the general population at a time point in life and may severely worsen the quality of life. First-line treatment has been based on antihistamines, and presently relies on the use of non-sedating, s
Chronic urticaria is a distressing disease that affects up to 1 % of the general population at a time point in life and may se
Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count.
Tamer F, Gulru Erdogan F, Dincer Rota D, Yildirim D, Akpinar Kara Y. Tamer F, et al. Acta Dermatovenerol Croat. 2019 Jun;27(2):101-106. Acta Dermatovenerol Croat. 2019. PMID: 31351504
Chronic spontaneous urticaria can be treated with several drugs such as antihistamines, leukotriene antagonists, cyclosporine, doxepin, hydroxychloroquine, colchicine, and corticosteroids. ...Medical records of 11 patients with chronic spontaneous u
Chronic spontaneous urticaria can be treated with several drugs such as antihistamines, leukotriene antagonists, cyclosporine,
28 results